Big Tech companies are helping propel third-quarter earnings growth, but some analysts are less optimistic about a handful of names reporting next week. As of Tuesday, roughly 42% of S & P 500 companies had reported financial results and collectively notched growth of more than 6%, according to FactSet. But the forecast for blended growth, which takes into account estimates for earnings that have yet to be reported, is a more measured 4.89%. To help investors prepare for what is still to come, CNBC Pro screened FactSet data to find stocks reporting next week where analysts are losing conviction. Among the names that surfaced are AIG and CVS Health . Stocks on the list are members of the S & P 500 Earnings are due next week Earnings per share estimates have been trimmed 10% or more over the past three and six months Stock in agriculture Archer-Daniels-Midland has pulled back more than 21% in 2024. Analysts have trimmed their earnings estimates by more than 21% over the past three months and 29% over the trailing six months. Third-quarter results are due out Tuesday. ADM YTD mountain Archer-Daniels stock. The firm paused carbon dioxide injections at an Illinois carbon capture and storage plant earlier in October, after discovering an underground leak . More recently, the company was sued for misconduct and lacking safety protocols . Shares of finance and insurance firm AIG have advanced nearly 14% in 2024. What’s more is analysts have lowered earnings estimates nearly 30% over the past three months and roughly 24% over the past six months. BMO Capital Markets analyst Michael Zaremski downgraded AIG stock to market perform from outperform earlier in October, citing concerns that AIG will continue to lag peers in the insurance sector and that the stock could face headwinds as market conditions overall remain soft. AIG YTD mountain AIG stock. “AIG’s shares have underperformed peers YTD (AIG +~13%) and sentiment remains more muted as investors digest AIG’s new operating structure, plus the potential for M & A [mergers & acquisitions],” Zaremski said in an Oct. 15 note. AIG will report third-quarter results on Monday. Other names on the list include chemical stocks Albemarle and Corteva .
